Viewing StudyNCT03860155

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-06 @ 12:50 PM
Last Modification Date: 2024-10-26 @ 1:04 PM
Study NCT ID: NCT03860155
Status: TERMINATED
Last Update Posted: 2021-11-17
First Post: 2019-01-31
Brief Title: Allogeneic ABCB5-positive Stem Cells for Treatment of Acute-on-Chronic Liver Failure
Sponsor: RHEACELL GmbH Co KG
Organization: RHEACELL GmbH Co KG
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Acute-On-Chronic Liver Failure
Keywords:
Name View
phase IIIa View
Acute-on-Chronic Liver Failure View
ACLF View
ABCB5 View
ATP Binding Cassette Subfamily B Member 5 View
allogeneic View
mesenchymal stem cells View
advanced therapy medicinal product View
somatic cell therapy View